Diagnostics & Research
The Diagnostics & Research industry has a total of 46 stocks, with a combined market cap of $840.42 billion, total revenue of $173.15 billion and a weighted average PE ratio of 46.81.
Market Cap
840.42B
Revenue
173.15B
Profits
17.95B
PE Ratio
46.81
Profit Margin
10.37%
Dividend Yield
0.20%
46 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 225.01B | 1.34% | 1,617,002 | 46.34B |
| 2 | DHR | Danaher Corporation | 147.56B | 1.44% | 2,951,051 | 25.11B |
| 3 | NTRA | Natera, Inc. | 46.87B | 1.37% | 1,032,919 | 2.71B |
| 4 | IQV | IQVIA Holdings Inc. | 43.43B | 2.13% | 1,127,718 | 16.98B |
| 5 | A | Agilent Technologies, Inc. | 42.68B | 0.97% | 3,130,660 | 7.37B |
| 6 | IDXX | IDEXX Laboratories, Inc. | 42.46B | -1.13% | 655,523 | 4.55B |
| 7 | WAT | Waters Corporation | 40.50B | 1.57% | 621,465 | 4.64B |
| 8 | ILMN | Illumina, Inc. | 32.20B | 2.95% | 1,771,940 | 4.49B |
| 9 | MTD | Mettler-Toledo International Inc. | 27.40B | -0.60% | 178,966 | 4.13B |
| 10 | LH | Labcorp Holdings Inc. | 26.90B | 1.24% | 643,928 | 14.35B |
| 11 | DGX | Quest Diagnostics Incorporated | 26.58B | 1.94% | 1,144,111 | 11.56B |
| 12 | GH | Guardant Health, Inc. | 21.88B | -0.82% | 1,745,453 | 1.18B |
| 13 | MEDP | Medpace Holdings, Inc. | 16.55B | 1.68% | 204,149 | 2.78B |
| 14 | RVTY | Revvity, Inc. | 14.61B | 3.44% | 2,101,523 | 2.91B |
| 15 | CRL | Charles River Laboratories International, Inc. | 13.93B | 3.34% | 606,454 | 4.00B |
| 16 | ICLR | ICON Public Limited Company | 12.33B | -0.97% | 893,167 | 8.29B |
| 17 | QGEN | Qiagen N.V. | 9.14B | 1.87% | 1,852,510 | 2.10B |
| 18 | TWST | Twist Bioscience Corporation | 8.21B | -0.80% | 1,900,198 | 431.80M |
| 19 | RDNT | RadNet, Inc. | 5.96B | 0.24% | 712,712 | 2.27B |
| 20 | SHC | Sotera Health Company | 5.41B | 1.50% | 1,460,161 | 1.22B |
| 21 | BLLN | BillionToOne, Inc. | 4.54B | 4.15% | 414,785 | 397.41M |
| 22 | ADPT | Adaptive Biotechnologies Corporation | 3.94B | 1.31% | 1,623,116 | 308.08M |
| 23 | VCYT | Veracyte, Inc. | 3.61B | 3.34% | 1,357,584 | 561.90M |
| 24 | GRAL | GRAIL, Inc. | 3.60B | 0.97% | 449,183 | 165.26M |
| 25 | WGS | GeneDx Holdings Corp. | 2.59B | 2.25% | 500,104 | 454.43M |
| 26 | CDNA | CareDx, Inc. | 2.57B | 1.29% | 681,984 | 458.09M |
| 27 | NEO | NeoGenomics, Inc. | 2.24B | -0.29% | 1,794,474 | 766.30M |
| 28 | PSNL | Personalis, Inc. | 1.79B | -1.93% | 2,073,406 | 69.67M |
| 29 | FRNM | Freenome, Inc. | 1.71B | 4.59% | 985,226 | 35.41M |
| 30 | OPK | OPKO Health, Inc. | 1.26B | 11.18% | 7,144,330 | 587.90M |
| 31 | CSTL | Castle Biosciences, Inc. | 1.02B | -0.06% | 199,812 | 357.28M |
| 32 | FLGT | Fulgent Genetics, Inc. | 551.41M | 2.30% | 412,422 | 323.93M |
| 33 | MYGN | Myriad Genetics, Inc. | 308.95M | 1.57% | 1,351,130 | 806.60M |
| 34 | BDSX | Biodesix, Inc. | 286.57M | 8.34% | 141,220 | 102.94M |
| 35 | XGN | Exagen Inc. | 181.93M | 5.48% | 244,295 | 71.12M |
| 36 | QUCY | Quantum Cyber N.V. | 134.51M | 8.11% | 1,323,203 | 537.08K |
| 37 | IMDX | Insight Molecular Diagnostics Inc. | 131.22M | 4.43% | 80,815 | 1.67M |
| 38 | MBAI | Check-Cap Ltd. | 99.10M | -1.22% | 51,179 | - |
| 39 | BNR | Burning Rock Biotech Limited | 96.50M | -0.76% | 3,617 | 74.58M |
| 40 | MDXH | MDxHealth SA | 67.75M | -1.43% | 207,107 | 114.02M |
| 41 | PRPO | Precipio, Inc. | 49.23M | -0.95% | 237,045 | 27.20M |
| 42 | ADVB | Advanced Biomed Inc. | 16.14M | -6.42% | 86,456 | - |
| 43 | NDRA | ENDRA Life Sciences Inc. | 9.69M | 22.58% | 135,862 | - |
| 44 | XWEL | XWELL, Inc. | 8.30M | 1.67% | 13,673 | 28.28M |
| 45 | BIAF | bioAffinity Technologies, Inc. | 5.26M | 47.95% | 46,005,782 | 5.90M |
| 46 | ISPC | iSpecimen Inc. | 3.75M | -0.67% | 56,645 | 466.30K |